Clinical Trials Directory

Trials / Completed

CompletedNCT03042936

Diabetes Prevention Program in Youth

Insulin Superheroes Club: Diabetes Prevention Program in Youth (12-month Supplement to the CDC DPP for Adults)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
University of Tennessee · Academic / Other
Sex
All
Age
7 Years – 15 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to test the effectiveness of an out-of-school diabetes prevention program for youth (ages 7-15) with a family history of pre-diabetes or type 2 diabetes.

Detailed description

The Insulin Superheroes Club (ISC) is based on the Diabetes Prevention Program for adults (Knowler WC et al., 2002), which was developed by the Centers for Disease Control and Prevention (CDC). We have adapted the curriculum for youth to serve a supplement to the adult program. This program lasts 12 months, and the goals are to improve participants' health and reduce their risk of developing pre-diabetes or type 2 diabetes. The ISC program includes 16 weekly (Phase 1), 3 bi-weekly (Phase 2), and 6 monthly (Phase 3) sessions. Sessions include 60 minutes of physical fitness and 30 minutes of education. The education portion includes interactive teaching of a health-related topic (e.g., nutrition, exercise, physiology, mindfulness, and stress reduction) using a hand-on learning activity (e.g., cooking, crafts, games, and role play). All physical fitness activities incorporate moderate intensity exercises (e.g., push-ups, yoga, basketball, tag, and dance).

Conditions

Interventions

TypeNameDescription
BEHAVIORALInsulin Superheroes Club CurriculumThis curriculum promotes healthier physical activity, nutrition, sleep, and stress coping practices. The intervention lasts 12-months: registration, six evaluation sessions (2-3 hours per evaluation: Weeks 1, 8, and 16, 6-month, 9-month, and 12-month), and 16-weekly, 3-bi weekly, 6-monthly educational and physical activity sessions each lasting 90 minutes.

Timeline

Start date
2015-03-01
Primary completion
2020-11-04
Completion
2020-11-04
First posted
2017-02-03
Last updated
2023-11-22
Results posted
2023-11-22

Source: ClinicalTrials.gov record NCT03042936. Inclusion in this directory is not an endorsement.